Skip to content

Ipsen Sustainability Reports

Ipsen S.A. is a global mid-sized biopharmaceutical company focused on the research, development, and commercialization of transformative medicines. Its core therapeutic areas include oncology, neuroscience, and rare diseases.

Sector: Manufacturing

Country: France

Exchange: Euronext Paris

LEI: 549300M6SGDPB4Z94P11

FIGI: BBG001SFCJ35

13 reports from 2014 to 2026